← Leaderboards
Jianfeng Xu
Wake Forest University Health Sciences
$13,367,512
Attributed
$14,297,279
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–11$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$14,297,279 · 8
By mechanism
R01$10,318,509 · 6
UC2$2,006,440 · 1
RC2$1,972,330 · 1
Top collaborators
- Elizabeth A. Platz3 shared
Others in their field
Top investigators on “Genotype”
- David R. Weir · University Of Michigan At Ann Arbor$303,033,420
- Richard A Gibbs · Baylor College Of Medicine$211,329,145
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Stacey Gabriel · Massachusetts Institute Of Technology$153,486,482
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$141,132,078
Research focus
GenotypeCancer RiskMalignant Neoplasm Of ProstateVariantGeneticResearch PersonnelPopulation StudyAffectDesignMalignant NeoplasmsCase ControlBaseGenesStagingGenome Wide Association StudyGenetic Predisposition To DiseaseResearch DesignProstateCase-Control StudiesGenomeJointsAllelesMapsInherited
Grant awards (27)
Genetic profiling in PCPT: prostate cancer risk, PSA levels, and chemoprevention$589,179
R01 · FY2011 · CA · contact PI
Confirmation of SNPs Associated with Aggressive PCa in a GWA Study$565,254
R01 · FY2011 · CA · contact PI
Clinical validity and utility of genomic targeted chemoprevention of PCa$2,006,440
UC2 · FY2010 · CA · contact PI
Genetic profiling in PCPT: prostate cancer risk, PSA levels, and chemoprevention$629,341
R01 · FY2010 · CA · contact PI
Confirmation of SNPs Associated with Aggressive PCa in a GWA Study$600,462
R01 · FY2010 · CA · contact PI
QTL mapping for genes regulating apoptosis capacity$247,921
R01 · FY2010 · CA · contact PI
Clinical validity and utility of genomic targeted chemoprevention of PCa$1,972,330
RC2 · FY2009 · CA · contact PI
Genetic profiling in PCPT: prostate cancer risk, PSA levels, and chemoprevention$641,014
R01 · FY2009 · CA · contact PI
Confirmation of SNPs Associated with Aggressive PCa in a GWA Study$603,750
R01 · FY2009 · CA · contact PI
QTL mapping for genes regulating apoptosis capacity$223,171
R01 · FY2009 · CA · contact PI
Confirmation of SNPs Associated with Aggressive PCa in a GWA Study$679,627
R01 · FY2008 · CA · contact PI
Association of inflammatory genes and prostate cancer$441,199
R01 · FY2008 · CA · contact PI
Interaction of PTEN and CDKN1B in Pca susceptibility$302,779
R01 · FY2008 · CA · contact PI
QTL mapping for genes regulating apoptosis capacity$222,836
R01 · FY2008 · CA · contact PI
Association of inflammatory genes and prostate cancer$437,498
R01 · FY2007 · CA · contact PI
Interaction of PTEN and CDKN1B in Pca susceptibility$381,746
R01 · FY2007 · CA · contact PI
Mapping Prostate Cancer Susceptibility Genes at 8p22-23$264,602
R01 · FY2007 · CA · contact PI
Association of inflammatory genes and prostate cancer$449,348
R01 · FY2006 · CA · contact PI
Interaction of PTEN and CDKN1B in Pca susceptibility$294,543
R01 · FY2006 · CA · contact PI
Mapping Prostate Cancer Susceptibility Genes at 8p22-23$273,649
R01 · FY2006 · CA · contact PI
Association of inflammatory genes and prostate cancer$503,814
R01 · FY2005 · CA
Mapping Prostate Cancer Susceptibility Genes at 8p22-23$281,372
R01 · FY2005 · CA
Interaction of PTEN and CDKN1B in Pca susceptibility$270,765
R01 · FY2005 · CA
Association of inflammatory genes and prostate cancer$522,927
R01 · FY2004 · CA
Interaction of PTEN and CDKN1B in Pca susceptibility$312,684
R01 · FY2004 · CA
Mapping Prostate Cancer Susceptibility Genes at 8p22-23$282,476
R01 · FY2004 · CA
Mapping Prostate Cancer Susceptibility Genes at 8p22-23$296,552
R01 · FY2003 · CA